As a result of the increasingly sensitive diagnostics and fast therapeutic measures, a positive trend towards higher survival rates of CAD and its sequelae is observed, thus simultaneously challenging Western healthcare systems with a growing cohort of CAD patients at risk of substantial morbidity and mortality ( 1 , 68 ).
← all excerpts
Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases.
1
—
—